Purpose <p>The primary aim of this study was to assess clinical and surgical safety for patients who underwent transition surgery from a percutaneous to an active transcutaneous bone conduction implant. A secondary aim was to report audiological changes and outcomes for quality of life post the transition surgery.</p> Methods <p>An observational, descriptive and prospective study was performed in a tertiary referral center. Patients who underwent transition surgery as part of their treatment were included. Clinical and surgical safety were assessed through intraoperative and postoperative complications and adverse events. The audiological outcomes were assessed with the Hearing in Noise Test, both fixed noise and adaptative noise measurements. Quality of life changes were evaluated using the Glasgow Benefit Inventory, postoperatively.</p> Results <p>The study of 23 cases (18 patients) found minor complications in 5.3% (6/113 follow-up points) and no major complications. Audiometric results showed no significant differences in speech understanding (fixed noise=-0.011%, <i>p</i> = 0.99; adaptive noise = 0.236dB, <i>p</i> = 0.617). Quality of life scores increased moderately (+ 27.0 ± 33.9), with notable gains in general health (+ 29.9) and social support (+ 31.8), and a modest improvement in physical well-being (+ 10.6).</p> Conclusions <p>The study showed that transitioning from a passive percutaneous to an active transcutaneous bone conduction implant is safe, with no major adverse events and only a few minor complications. The audiological outcomes with transcutaneous implants were maintained with respect to percutaneous implants, while quality of life improvements were notable in general health and social support. Clinicians should use these insights to guide patient discussions and tailor post-operative care.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Clinical and surgical safety in patients transitioning from percutaneous to transcutaneous active bone conduction implants

  • Leonardo Elías Ordóñez Ordóñez,
  • Gabriela Elizabeth Corredor García,
  • Jorge Medina-Parra,
  • Esther Sofía Angulo Martínez,
  • Silvia Carolina Vanegas,
  • Estefany Catherine Hernández,
  • Maja Magdalena Olsson,
  • Sindi Amaya

摘要

Purpose

The primary aim of this study was to assess clinical and surgical safety for patients who underwent transition surgery from a percutaneous to an active transcutaneous bone conduction implant. A secondary aim was to report audiological changes and outcomes for quality of life post the transition surgery.

Methods

An observational, descriptive and prospective study was performed in a tertiary referral center. Patients who underwent transition surgery as part of their treatment were included. Clinical and surgical safety were assessed through intraoperative and postoperative complications and adverse events. The audiological outcomes were assessed with the Hearing in Noise Test, both fixed noise and adaptative noise measurements. Quality of life changes were evaluated using the Glasgow Benefit Inventory, postoperatively.

Results

The study of 23 cases (18 patients) found minor complications in 5.3% (6/113 follow-up points) and no major complications. Audiometric results showed no significant differences in speech understanding (fixed noise=-0.011%, p = 0.99; adaptive noise = 0.236dB, p = 0.617). Quality of life scores increased moderately (+ 27.0 ± 33.9), with notable gains in general health (+ 29.9) and social support (+ 31.8), and a modest improvement in physical well-being (+ 10.6).

Conclusions

The study showed that transitioning from a passive percutaneous to an active transcutaneous bone conduction implant is safe, with no major adverse events and only a few minor complications. The audiological outcomes with transcutaneous implants were maintained with respect to percutaneous implants, while quality of life improvements were notable in general health and social support. Clinicians should use these insights to guide patient discussions and tailor post-operative care.